Developments in the pharmacotherapeutic management of osteoporosis

Author： Close Pierre Neuprez Audrey Reginster Jean-Yves

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.12, 2006-08, pp. : 1603-1615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments in the pharmacotherapeutic management of spontaneous preterm labor

By Kam KY Ronald Lamont Ronald F

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1153-1168

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapeutic management of autism

By Posey D.J. McDougle C.J.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 587-600

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapeutic options for the management of myocardial infarction

By Cheng Judy WM

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1153-1168

Informa Healthcare

Access to resources Recommend Favorite

Future Developments in Osteoporosis Therapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 4, 2009-01 ,pp. : 371-384

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal Pharmacotherapeutic Management of Acute Lymphoblastic Leukaemia in the Elderly

By Rousselot Philippe

Drugs & Aging, Vol. 28, Iss. 9, 2011-09 ,pp. : 749-764

Adis International

Access to resources Recommend Favorite